A great deal
of prenatal and perinatal management is based on diagnosis and evaluation of
disorders by imaging. While this is indeed helpful, this type of diagnosis does
little to describe the pathophysiology of the disease process. In this project,
we are investigating the biomarkers within the serum, cord blood, and amniotic
fluid that can be used to provide insight into underlying mechanisms that may
be used to enhance diagnosis, monitoring, and treatment options in the future.